-
Suzhou Porton Biologics Partners with Yinjia Biosciences for CGT Development
China-based contract development and manufacturing organization (CDMO) Suzhou Porton Biologics Ltd has struck a partnership with Yinjia Biosciences, a protein reagents and diagnostic products developer based in Shanghai. The agreement aims to enhance the development and industrialization of cell and gene therapy (CGT) by leveraging the strengths of both companies.…
-
Yinjia Biosciences Raises RMB 100 Million in Series A Financing Round
Yinjia Biosciences, a Shanghai-based developer of protein reagents and diagnostic products, has reportedly raised close to RMB 100 million (USD 14.76 million) in a Series A financing round. The funding was led by CMB International, with participation from Suzhou Xinhe Guoqing Venture Capital Partnership Ltd. The proceeds will be used…
